戻る Agendas
Session 0402 Application of Bayesian Methods for Clinical Trials
Session Chair(s)
Bingming Yi
Director
GSK, China
Speaker(s)
Maximizing Return on Investment in Designing Phase II Clinical Trials
Cong Chen, PHD
Merck & Co., Inc., United States
Director
A Bayesian prediction model between biomarker and clinical endpoint for dichotomous variables
Yang Song
MSD, China
Sr. Prin. Scientist, Biostatistics
A case study for a Bayesian approach to the assessment of safety for biosimilar and its application to bridging study (CN&EN)
Jerry Wang
Pfizer, United States